Clinical Trials Browser

Has results × Carcinoma, Hepatocellular × Temozolomide × Clear all

NCT01205828 2025-02-12

ABT-888 and Temozolomide for Liver Cancer

Phase 2 Terminated

16 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms